Bio Protocol vs Hedera — how do they compare? Bio Protocol trades at Rp434.19 (market cap Rp983,84M, Rp162,92M 24h volume), while Hedera trades at Rp1,166 (market cap Rp50,96T, Rp580,75M 24h volume). The key difference: Hedera is far larger — about 51797× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 43,8B / 50B HBAR (88%) for Hedera. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Hedera for 56 Days on average.
| BIO | HBAR | |
|---|---|---|
Market Cap | Rp983,84M | Rp50,96T |
Volume (24h) | Rp162,92M | Rp580,75M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 43,8B / 50B HBAR (88%) |
Typical Hold Time | 18 Days | 56 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Hedera (HBAR) is currently trading at Rp1,169.76 with a market cap of Rp51.08T, showing bearish technical signals with moving averages indicating strong selling pressure while oscillators remain neutral. The token is trading near key support levels with RSI_6 at 20.52 suggesting potential oversold conditions. Current price action is testing support at Rp1,165 with resistance at Rp1,187. No major protocol updates or ecosystem developments were reported recently.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from oversold RSI levels, while major risks involve continued downward pressure and lack of positive catalyst. Investors should monitor support breaks and trading volume patterns for directional cues.
What Pluang investors did over the last 30 days
Latest headlines on both assets
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Hedera (HBAR) is the most used, sustainable, enterprise-grade public network for the decentralized economy that allows individuals and businesses to create powerful decentralized applications (DApps). Hedera Hashgraph isn’t built on top of a conventional blockchain. Instead, it introduces a completely novel type of distributed ledger technology known as a Hashgraph. This technology allows it to improve upon many blockchain-based alternatives in several key areas, including speed, cost, and scalability.
Read more on HBAR →